High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.0M
$1,024,660
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KYMR
S
Kymera Therapeutics, Inc.
Ridloff Elena
• Director
10b5-1 SellΔOwn -73.9%
2026-04-01
$392,922x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -73.9%
|
2026-04-01 | $392,922x2 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-31 | $631,739 | S | Form 4 |